Bafna Pharmaceuticals Limited (NSE:BAFNAPH)

Market Cap	3.28B +90.8%
Revenue (ttm)	1.55B +6.5%
Net Income	111.00M +167.3%
EPS	4.69 +167.2%
Shares Out	23.66M
PE Ratio	29.53
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,649
Open	138.00
Previous Close	131.90
Day's Range	134.00 - 138.49
52-Week Range	72.01 - 202.06
Beta	0.18
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1981
• Employees: 406
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BAFNAPH

Financial Performance

In fiscal year 2026, Bafna Pharmaceuticals's revenue was 1.55 billion, an increase of 6.52% compared to the previous year's 1.46 billion. Earnings were 111.00 million, an increase of 167.30%.